Catalyst Pharmaceuticals, Inc. (DELISTED) (CPRX:DL)
31.49
0.00 (0.00%)
USD |
NASDAQ |
Jul 24, 16:00
Catalyst Pharmaceuticals 1 Year Total Returns (Daily) : 49.81% for July 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| July 24, 2026 | 49.81% |
| July 23, 2026 | 45.99% |
| July 22, 2026 | 50.67% |
| July 21, 2026 | 49.88% |
| July 20, 2026 | 49.74% |
| July 17, 2026 | 46.81% |
| July 16, 2026 | 48.68% |
| July 15, 2026 | 50.31% |
| July 14, 2026 | 45.65% |
| July 13, 2026 | 44.34% |
| July 10, 2026 | 44.03% |
| July 09, 2026 | 45.53% |
| July 08, 2026 | 51.66% |
| July 07, 2026 | 50.31% |
| July 06, 2026 | 46.78% |
| July 02, 2026 | 46.62% |
| July 01, 2026 | 48.37% |
| June 30, 2026 | 44.84% |
| June 29, 2026 | 44.44% |
| June 26, 2026 | 43.90% |
| June 25, 2026 | 45.87% |
| June 24, 2026 | 42.37% |
| June 23, 2026 | 41.95% |
| June 22, 2026 | 39.59% |
| June 18, 2026 | 37.57% |
| Date | Value |
|---|---|
| June 17, 2026 | 35.23% |
| June 16, 2026 | 32.45% |
| June 15, 2026 | 33.32% |
| June 12, 2026 | 29.11% |
| June 11, 2026 | 23.46% |
| June 10, 2026 | 19.12% |
| June 09, 2026 | 21.28% |
| June 08, 2026 | 20.91% |
| June 05, 2026 | 23.30% |
| June 04, 2026 | 23.72% |
| June 03, 2026 | 25.57% |
| June 02, 2026 | 25.58% |
| June 01, 2026 | 25.28% |
| May 29, 2026 | 27.05% |
| May 28, 2026 | 27.51% |
| May 27, 2026 | 26.09% |
| May 26, 2026 | 27.93% |
| May 22, 2026 | 29.66% |
| May 21, 2026 | 28.62% |
| May 20, 2026 | 26.62% |
| May 19, 2026 | 26.72% |
| May 18, 2026 | 28.15% |
| May 15, 2026 | 31.12% |
| May 14, 2026 | 33.16% |
| May 13, 2026 | 31.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Inovio Pharmaceuticals, Inc. | -36.22% |
| Indivior Pharmaceuticals, Inc. | 48.77% |
| Exelixis, Inc. | 41.21% |
| United Therapeutics Corp. | 64.26% |
| Krystal Biotech, Inc. | 127.1% |